Login
Sat 28 Nov 2009 | 12:37 EST
You are here:Home > Business & Finance > Industry Summits > Summit Notebook > Article
Home
Business & Finance
Markets
Deals
Industries
Industry Summits
Past Summits
Stocks
Stock Buzz
Funds
ETFs
Currencies
Commodities
Options
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Mobile
Podcasts
Newsletters
You Witness News
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
Find a financial adviser
About Reuters

Industry Summits

Summit Notebook

Exclusive outtakes from industry leaders

« Previous Post
Next Post »
November 15th, 2007

AUDIO-Medco eyes expansion in Europe to fuel long-term growth

Post a comment
Posted by: Ed Tobin
Tags: Health, Summit

medco2.jpg

With at least $60 billion in U.S. annual sales of brand name medicines going off patent between now and 2012 — Medco is in a sweet spot.

The question on investors’ minds? What will spur growth beyond the generic windfall five years out? CEO David Snow told the Reuters Health Summit expansion plans in Europe will be one of those drivers, and said talks are going on right now.

Post a comment |

Post Your Comment

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word

House Rules:
  • We moderate all comments and will publish everything that advances the post directly or with relevant tangential
  • We try not to publish comments that we think are offensive or appear to pass you off as another person, and we will be conservative if comments may be considered libelous.information.